Consistent with previous observations13–16, our results demonstrated that the mMDSC subset (CD14+/CD15−/HLA-DR−) constitutes the majority of MDSCs detected in the circulation of patients with primary or metastatic liver tumors and that there is an approximately twofold increase in the frequency of these cells in patients with HCC. The gene discussed is CD14; the disease is hepatocellular carcinoma.